Xenetic Biosciences XBIO
NASDAQ XBIO
$2.32 +0.06 (+2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Debt Ratio (2011 - 2016)

Updated

Xenetic Biosciences' Debt Ratio came in at 0.08 for Q3 2016, down 58.5% from 0.20 a year earlier.

Analysis

Xenetic Biosciences (XBIO) Debt Ratio (2011 - 2016) Analysis & Trends

For FY2015, Xenetic Biosciences' Debt Ratio was 0.22.

  • Going back by year, Debt Ratio was 0.87 in FY2013 (+33.2%), 0.66 in FY2012 (-31.4%) and 0.96 in FY2011.
  • The Q3 2016 figure represents the lowest quarterly Debt Ratio in data going back to Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Xenetic Biosciences 5.30 Mn -20.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 0.08
Mar 31, 2016 0.38
Dec 31, 2015 0.22
Sep 30, 2015 0.20
Nov 30, 2013 1.19
Aug 31, 2013 0.87
May 31, 2013 0.77
Feb 28, 2013 0.79
Nov 30, 2012 0.60
Aug 31, 2012 0.66
May 31, 2012 0.70
Feb 29, 2012 0.85
Aug 31, 2011 0.96
API Access

Xenetic Biosciences Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=XBIO&period=max&api_key=YOUR_API_KEY